Celgene Corporation (NASDAQ:CELG) missed earnings on 2 occasions

Celgene Corporation (NASDAQ:CELG) missed earnings on 2 occasions

Celgene Corporation (NASDAQ:CELG) missed earnings on 2 occasions

Celgene Corporation (NASDAQ:CELG) is projected to declare fiscal first quarter financial results right before the stock market’s official open on April 27, 2017. The stock added about 8.8 percent in price since last results when it was at $113.98 a share. Based on the most relevant past-periods data, there is an 53.57 percent probability for this firm’s share price to go down following next quarterly results. Earnings reaction history tells us that the equity price moved down 15 times out of last 28 reported quarters. It has beaten earnings-per-share estimates 75% of the time in its last 12 earnings reports. It fell short of earnings estimates on 2 occasions, and it has met expectations 1 time.

Here’s how traders responded to CELG earnings announcements over the past few quarters.

Celgene Corporation (CELG) Earnings Surprises & Reaction

Given its history, the average earnings announcement surprise was 5.08 percent over the past four quarters. Back on January 26, 2017, it posted earnings per-share earnings at $1.41 which missed the consensus $1.43 projection (negative surprise of-1.4%). For the quarter, revenue came in at 2.98B versus consensus estimate of 3.02B. The stock dropped -2.15 percent the session following the earnings reports were released, and on 7th day price change was 0 percent.

On October 27, 2016, it reported earnings at $1.39 a share compared with the consensus estimate of $1.31 per share (positive surprise of 6.11%). Revenue of 2.98B for that quarter was above the $2.83B analysts had expected. The stock climbed 6.41% the day following the earnings announcement, and on 7th day price change was 4.51%.

On July 28, 2016, it recorded $1.28 a share in earnings which topped the consensus estimate of $1.24 (positive surprise of 3.23%). Revenue for the quarter was $2.75B while analysts called for revenues to be $2.7B. The stock gained 2.91% the day following the earnings data was made public, and on 7th day price change was 7.43%.

On April 28, 2016, it announced earnings per share at $1.18 versus the consensus estimate of $1.05 per share (positive surprise of 12.38%). That came on revenues of $2.51B for that period. Analysts had expected $2.58B in revenue.

Celgene Corporation Earnings Estimates

As Q1 earnings announcement date approaches, Wall Street is expecting earnings per share of $1.63. The analysts’ present consensus range is $1.46-$1.86 for EPS. The market consensus range for revenue is between $2.85B and $3.26B, with an average of $3.04B.

Celgene Corporation (NASDAQ:CELG) last ended at $124.43, sending the company’s market cap near $96.8B. The consensus 12-month price target from analysts covering the stock is $140.13. The share price has declined -2.02% from its top level in 52 weeks and dropped 7.5% this year. It recently traded in a range of $123.01-$124.57 at a volume of 2833118 shares. The recent trading ended with the price nearly 0.74 higher for the last 5 trading days, rebounding 31.83% from its 52-week low.


Add Comment

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.